Our Team

With 100-plus years of collective leadership, our team fuses capital-project expertise with deep pharmaceutical operations to move programs from concept through global commercialization. They have conceived, funded, built, and run GMP facilities on three continents while protecting margins in fiercely competitive markets—delivering dozens of sterile product launches right-first-time, on schedule, and in full regulatory compliance. 

Marrying capital-project expertise with deep pharmaceutical operations, our engineering and operations leaders have experience deploying more than US $600 million in build-outs across North America, Europe, and Asia. From greenfield design through regulatory approval and steady-state production, they turn complex requirements into inspection-ready facilities that compress time-to-market for parenteral products—liquid vials, lyophilized drugs, pre-filled syringes, and cartridges—while safeguarding margins worldwide. 

Our finance leadership combines decades of capital-markets acumen with hands-on experience running large-scale pharmaceutical operations worldwide. From front-end capital-project planning and funding to day-to-day global supply-chain management, they align financial strategy with operational reality—securing the right capital at the right time, structuring international partnerships, and de-risking every phase of execution. This seamless blend of financial rigor and deep pharma know-how protects margins and fuels sustainable growth across the entire product lifecycle. 

Our commercialization specialists bridge capital-project execution and deep pharmaceutical operations, steering products from early portfolio selection to post-market optimization. Drawing on global launch experience, they synchronize regulatory strategy, competitive intelligence, market access, and supply-chain ramp-up—working hand-in-hand with our finance, engineering, and manufacturing teams. The result: differentiated sterile therapies that reach worldwide markets faster and sustain commercial impact over the full product lifecycle.